Pharmaceutical
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
OEM & ODM
Veterinary raw materials
WeChat: 15091775531
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Megestrol Acetate API Raw Material
Product Overview:
China Factory Supply Pharmaceutical Raw Materials Megestrol Acetate Powder|Megestrol Acetate API China Manufacturers, Megestrol Acetate CAS 595-33-5 Megestrol Acetate API Powder.
Megestrol Acetate API Raw Material Attributes
Product Name: Megestrol Acetate API Raw Material
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Specification: 99% min Megestrol Acetate
Test Method: HPLC
CAS: 595-33-5
MF: C24H32O4
Sample: Megestrol Acetate Powder
Keywords: Megestrol Acetate Powder, Megestrol Acetate API, Megestrol Acetate API Manufacturers
Megestrol Acetate API Raw Material Details
Use and synthesis of Megestrol Acetate:
Megestrol acetate (BDH1298, SC10363) was a synthetic progesterone acetate that inhibited HegG2 with IC50 of 260μM.
Chemical properties of Megestrol Acetate:
White or yellowish crystalline powder (methanol), odorless and tasteless. Melting point 214-216℃. Soluble in acetone, slightly soluble in ethanol, ether, insoluble in water.
Megestrol Acetate tablets: Indicated for the palliative care of hormone-dependent tumors, including endometrial cancer and breast cancer.
Megestrol Acetate dispersible tablets: semi-synthetic progesterone derivatives, mainly used in the treatment of advanced breast cancer and advanced endometrial cancer, kidney cancer, prostate cancer and ovarian cancer also have some efficacy. And can improve appetite and cachexia in patients with advanced cancer.
Megestrol Acetate capsules/Soft capsules: Used to treat advanced breast cancer and advanced endometrial cancer, and has some efficacy in kidney, prostate, and ovarian cancer. And can improve the appetite and cachexia of patients with advanced tumors.
Pharmacological effects of Megestrol Acetate:
This product is a semi-synthetic progesterone derivative, which has certain inhibitory effect on hormone-dependent tumors. Its mechanism of action is the same as that of meprogesterone, which may control the development and growth of ovarian follicles by influencing the secretion of pituitary gonadotropin, thus reducing the production of estrogen. It acts on estrogen receptors, prevents their synthesis and reuse, interferes with their binding to estrogen, and inhibits the growth of tumor cells. In addition, it can antagonize glucocorticoid receptors and interfere with the interaction between steroid hormone receptors and regulatory proteins related to cell growth and differentiation.
Megestrol acetate (BDH1298, SC10363) was a synthetic progesterone acetate that inhibited HegG2 with IC50 of 260μM.
Chemical properties of Megestrol Acetate:
White or yellowish crystalline powder (methanol), odorless and tasteless. Melting point 214-216℃. Soluble in acetone, slightly soluble in ethanol, ether, insoluble in water.
Megestrol Acetate tablets: Indicated for the palliative care of hormone-dependent tumors, including endometrial cancer and breast cancer.
Megestrol Acetate dispersible tablets: semi-synthetic progesterone derivatives, mainly used in the treatment of advanced breast cancer and advanced endometrial cancer, kidney cancer, prostate cancer and ovarian cancer also have some efficacy. And can improve appetite and cachexia in patients with advanced cancer.
Megestrol Acetate capsules/Soft capsules: Used to treat advanced breast cancer and advanced endometrial cancer, and has some efficacy in kidney, prostate, and ovarian cancer. And can improve the appetite and cachexia of patients with advanced tumors.
Pharmacological effects of Megestrol Acetate:
This product is a semi-synthetic progesterone derivative, which has certain inhibitory effect on hormone-dependent tumors. Its mechanism of action is the same as that of meprogesterone, which may control the development and growth of ovarian follicles by influencing the secretion of pituitary gonadotropin, thus reducing the production of estrogen. It acts on estrogen receptors, prevents their synthesis and reuse, interferes with their binding to estrogen, and inhibits the growth of tumor cells. In addition, it can antagonize glucocorticoid receptors and interfere with the interaction between steroid hormone receptors and regulatory proteins related to cell growth and differentiation.
